Scailyte AG | Finanzwire

Basculer en Français

8295	Companies
114833	Keywords
55274	Articles
62430	Press releases

Home
Companies
Scailyte AG

BRIEF

published on 07/08/2024 at 18:05, 4 months 12 days ago

Scailyte Strengthens Its Leadership with Key Appointments

Precision Medicine Leadership Scailyte Biomarker Discovery AI-driven Translational Platform
PRESS RELEASE

published on 07/08/2024 at 18:00, 4 months 12 days ago

Scailyte Strengthens Its Leadership
Scailyte appoints Tim Foley as Chief Business Officer, Jean-Pierre Rosat as Executive Chair, and Darrin Crisitello as member of the BoD. Expansion of leadership team to drive growth and presence in North America

Precision Medicine Leadership Team Scailyte Biomarker Discovery AI-driven Analysis
BRIEF

published on 06/14/2024 at 14:05, 5 months 6 days ago

Scailyte Announces Virginia Savova, PhD as a Strategic and Scientific Advisor

Precision Medicine Scailyte Virginia Savova Single-cell Biomarker
PRESS RELEASE

published on 06/14/2024 at 14:00, 5 months 6 days ago

Scailyte Announces Virginia Savova, PhD as a Strategic and Scientific Advisor
Scailyte appoints Virginia Savova, PhD, as a Strategic and Scientific Advisor, enhancing expertise in single-cell omics and AI for biomarker discovery

AI Scailyte Virginia Savova Biomarker Discovery Single-cell Omics
BRIEF

published on 02/26/2024 at 16:05, 8 months 23 days ago

ScaiPod: A New Initiative to Transform Immuno-Oncology

Immuno-oncology Scailyte ScaiPod Cancer Biomarkers
PRESS RELEASE

published on 02/26/2024 at 16:05, 8 months 23 days ago

ScaiPod: Revolutionizing Immuno-Oncology With Multi-Omics and AI at Scale
Scailyte introduces ScaiPod, a multi-omics initiative in immuno-oncology to develop predictive biomarkers for ICI response and precision oncology. Academic-industry partnership drives groundbreaking clinical research

Precision Oncology Immuno-oncology Scailyte ScaiPod Multi-omics

Accesswire

Published on 11/21/2024 at 10:03, 39 minutes ago

Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Published on 11/21/2024 at 10:00, 42 minutes ago

BluSky Carbon JV Entity BluMountain Enters into JV Partnership in Southeastern USA
Published on 11/21/2024 at 09:00, 1 hour 42 minutes ago

ProScore Announces Domestic Content Solution for Inflation Reduction Act Requirements
Published on 11/21/2024 at 00:35, 10 hours 7 minutes ago

Vision Marine Technologies Establishes a Strategic Hub for Electric Boat Sales, Rentals, and Distribution, Marking a Milestone at Dania Pointe’s Grand Opening of Aileron Residences
Published on 11/21/2024 at 00:25, 10 hours 17 minutes ago

Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 10:30, 12 minutes ago

MS Industrie AG publishes unaudited key figures for the first 3 quarters 2024
Published on 11/21/2024 at 10:04, 37 minutes ago

Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:02, 40 minutes ago

Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:00, 42 minutes ago

Nabaltec AG continues solid earnings performance in third quarter of 2024
Published on 11/21/2024 at 10:00, 42 minutes ago

Deutsche Beteiligungs AG: Successful final closing of DBAG ECF IV

Les Echos

Published on 11/21/2024 at 06:58, 3 hours 44 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 15 hours 22 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 16 hours 57 minutes ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 16 hours 57 minutes ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 2 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE